Found 50 matching trials
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD PHASE1 Therapy of severe intestinal graft-versus-host disease (GVHD) despite the i...
Show More Location
Pavlov First Saint-Petersburg State Medical University
Learn More & Join Trial
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis PHASE1 This study will assess safety as well as establish a Recommended Phase II d...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Study of Ruxolitinib and Duvelisib in People With Lymphoma PHASE1 This study will test the safety of ruxolitinib, given at one dose that does...
Show More Location
University of Miami (Data Collection Only)
Learn More & Join Trial
A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors PHASE1 The goal of this clinical trial is to learn how roginolisib works in compar...
Show More Location
Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia
Learn More & Join Trial
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia PHASE1 This study will test if adding ruxolitinib to standard multi-drug chemother...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib PHASE2 This was an open-label, randomized, dose-finding study in patients with pri...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma PHASE2 The purpose of this study was to determine clinical efficacy and safety of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis PHASE1 This Phase 1b, multicenter, open-label study aims to evaluate the safety, p...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia PHASE1 With this research study has following goals
* To confirm the highest tole...
Show More Location
Lucile Packard Children's Hospital Stanford
Learn More & Join Trial
DEP-Ru Regimen as a Salvage Therapy for HLH PHASE3 This study aimed to investigate the efficacy and safety of ruxolitinib toge...
Show More Location
Beijing Friendship Hospital, Capital Medical University
Learn More & Join Trial